v3.25.2
Revenue Recognition from Collaboration and License Agreements (Tables)
6 Months Ended
Jun. 30, 2025
Disaggregation of Revenue [Line Items]  
Schedule of Revenue From Collaboration and License Agreements

The following table presents revenue from collaboration and license agreements:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

Bristol-Myers Squibb Collaboration and License Agreement

 

$

250

 

 

$

 

 

$

250

 

 

$

2,589

 

Roche Collaboration and License Agreement

 

 

 

 

 

1,073

 

 

 

 

 

 

50,888

 

Total revenue

 

$

250

 

 

$

1,073

 

 

$

250

 

 

$

53,477